Join Partners4Access for an exclusive in-person event in Zug, Switzerland, on Tuesday, 13th May 2025, where we bring together leading experts, industry peers, and stakeholders in rare disease, cell & gene therapy, and market access.
This highly interactive event will explore the latest EU market access challenges, including Joint Clinical Assessment (JCA), PICO selection and the EU Pharmaceutical stratgey, equipping you with the insights and strategies needed to future-proof your product for success in Europe.
Our event will bring together leading experts and industry stakeholders to discuss the latest EU market access challenges, including Joint Clinical Assessment (JCA) and EU pharma regulations & launch conditionally.
Gain practical expertise navigating the evolving JCA framework
Participate in a hands-on workshop led by market access specialists
Understand key regulatory hurdles & launch conditionality for ODs/ATMPs
Network with senior industry leaders & peers in an intimate setting
Where, when and what. Join us in the perfect location.
Sophie Schmitz
Darren Callanan, Pina Haberl, Johann Sanseau
Darren Callanan, Pina Haberl, Johann Sanseau
Sam Morrison, Rosa Faria-Matthews
Sophie Schmitz
